Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2012
12/06/2012US20120309767 Process for the preparation of alpha form of imatinib mesylate
12/06/2012US20120309766 Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors
12/06/2012US20120309765 5-anilinoimidazopyridines and methods of use
12/06/2012US20120309764 Heteroaromatic aryl triazole derivatives as PDE10A enzyme inhibitors
12/06/2012US20120309763 Antifungal composition intended to be applied to a perforated nail
12/06/2012US20120309762 Cytochrome p450 oxidase inhibitors and uses thereof
12/06/2012US20120309761 Fast-response photochromic nanostructured contact lenses
12/06/2012US20120309760 Piperazine compound having a pgds inhibitory effect
12/06/2012US20120309759 Screening Method and Compounds for Modulating Telomerase Activity
12/06/2012US20120309758 Modulators of atp-binding cassette transporters
12/06/2012US20120309757 N-biphenylmethylindole modulators of pparg
12/06/2012US20120309756 Compounds modulating c-fms and/or c-kit activity and uses therefor
12/06/2012US20120309755 Novel compounds
12/06/2012US20120309754 Pyrazolopyrimidine compounds and their use as pde10 inhibitors
12/06/2012US20120309753 Method of dissolving antifungal agent, and compositions with a high concentration of antifungal agent, suitable for application to the nail
12/06/2012US20120309751 Tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof
12/06/2012US20120309750 5-membered heterocycle derivatives and manufacturing process thereof
12/06/2012US20120309749 Piroxicam-Containing Transdermally Absorbable Preparation
12/06/2012US20120309748 Conjugated psychotropic drugs and uses thereof
12/06/2012US20120309747 Protein kinase inhibitors
12/06/2012US20120309746 Triazolopyridine compounds
12/06/2012US20120309745 HIV Integrase Inhibitors
12/06/2012US20120309744 Dosing regimens and methods for treating or preventing hepatocellular carcinoma
12/06/2012US20120309743 Thiolactams and uses thereof
12/06/2012US20120309742 Use of metabotropic glutamate receptors
12/06/2012US20120309741 Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors
12/06/2012US20120309740 Pharmaceutical Compositions Having Improved Dissolution Profiles For Poorly Soluble Drugs
12/06/2012US20120309739 Akt / pkb inhibitors
12/06/2012US20120309738 Novel compounds
12/06/2012US20120309737 3,6-Diazabicyclo[3.1.1]heptanes as Neuronal Nicotinic Acetycholine Receptor Ligands
12/06/2012US20120309736 Novel cyclic benzimidazole derivatives useful anti-diabetic agents
12/06/2012US20120309735 Aminopyrimidines as syk inhibitors
12/06/2012US20120309734 Combretastatin derivatives and uses therefor
12/06/2012US20120309733 Composition
12/06/2012US20120309732 METHOD FOR INHIBITION OF TUMOR CELL GROWTH USING (22R)-5alpha-LANOSTA-8,24-DIEN-3Beta,15alpha,21-TRIOL
12/06/2012US20120309731 Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
12/06/2012US20120309730 Oxysterols that activate liver x receptor signaling and inhibit hedgehog signaling
12/06/2012US20120309729 Barrier composition
12/06/2012US20120309728 New steroid inhibitors of pgp for use for inhibiting multidrug resistance
12/06/2012US20120309727 Combinations comprising antimuscarinic agents and pde4 inhibitors
12/06/2012US20120309726 Combinations comprising antimuscarinic agents and pde4 inhibitors
12/06/2012US20120309725 Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
12/06/2012US20120309724 Neprilysin inhibitors
12/06/2012US20120309723 Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases
12/06/2012US20120309722 Therapeutic regimens for the treatment of immunoinflammatory disorders
12/06/2012US20120309721 Method for providing neuroprotection
12/06/2012US20120309720 Compositions and methods for treatment of glaucoma
12/06/2012US20120309719 (22e)-2-methylene-26,27-cyclo-22-dehydro-1alpha-hydroxy-19-norvitamin d3 derivatives
12/06/2012US20120309717 Compounds, methods and pharmaceutical compositions for inhibiting parp
12/06/2012US20120309716 Motor Function Improver
12/06/2012US20120309715 Use of Simethicone in Constipated Patients
12/06/2012US20120309714 Heteroaromatic Phenylimidazole derivatives as PDE10A enzyme inhibitors
12/06/2012US20120309713 N-Cyclopropyl-(20R)-2-Methylene-19,26,27-Trinor-25-Aza-Vitamin D Analogs and Their Uses
12/06/2012US20120309712 Compositions Comprising Dietary Fat Complexer and Methods for Their Use
12/06/2012US20120309711 Modified pectins, compositions and methods related thereto
12/06/2012US20120309710 Compound sea cucumber preparation and manufacturing method thereof
12/06/2012US20120309709 Ion-Channel Regulator Compositions and Methods of Using Same
12/06/2012US20120309708 Method for treatment of lacto-n-biose-containing solution
12/06/2012US20120309707 Sulphated disaccharides for the treatment of neurodegenerative and/or neurovascular diseases
12/06/2012US20120309706 Combined treatment of pancreatic cancer with gemcitabine and masitinib
12/06/2012US20120309705 Novel 3'-deoxy-3'-methylidene-beta-l-nucleosides
12/06/2012US20120309704 Compositions for treatment of chemoresistant and/or potentially chemoresistant leukaemias
12/06/2012US20120309703 Agonists of bitter taste receptors and uses thereof
12/06/2012US20120309702 Dynamic inhibitors of heat shock protein 90
12/06/2012US20120309701 Compounds and methods for treating bacterial infections
12/06/2012US20120309700 Development and evaluation of novel chinese materia medica preparations
12/06/2012US20120309699 Compounds having anti-inflammatory activity
12/06/2012US20120309698 HIV Integrase Inhibitors
12/06/2012US20120309693 Methods to Accelerate Tissue and Wound Healing Rates and Reduce Swelling and Scar Formation
12/06/2012US20120309677 Methods for regulating blood glucose levels
12/06/2012US20120309672 Treatment of extracellular matrix to reduce inflammation
12/06/2012US20120309628 Bioactive agent delivery particles
12/06/2012US20120309626 Hyperbranched polyester with a hydrophobic nucleus for solubilizing poorly soluble active substances
12/06/2012US20120309623 Surface-modified hydrogels and hydrogel microparticles
12/06/2012US20120308671 Nasal ointment based on white petroleum jelly
12/06/2012US20120308668 Mazindol combination in the treatment of attention deficit/hyperactivity
12/06/2012US20120308663 Lipid nanocapsules, method for preparing same and use thereof as a drug
12/06/2012US20120308659 Pellet formulation for the treatment of the intenstinal tract
12/06/2012US20120308658 Methods and compositions to treat hemorrhagic conditions of the brain
12/06/2012US20120308655 Delivery Carrier
12/06/2012US20120308654 Abuse-proofed dosage form
12/06/2012US20120308652 Oral form of administration comprising entecavir
12/06/2012US20120308651 Salts of benzimidazolyl pyridyl ethers and formulations thereof
12/06/2012US20120308648 Methods of treating hot flashes with formulations for transdermal or transmucosal application
12/06/2012US20120308647 Use of mir-30e to treat vascular lesions
12/06/2012US20120308645 Compositions and methods for sirna inhibition of hif-1 alpha
12/06/2012US20120308644 Compositions for mucosal delivery of agents
12/06/2012US20120308643 Liposomal mitigation of drug-induced long qt syndrome and potassium delayed-rectifier current
12/06/2012US20120308642 Inhibiting hepatitis c viral replication with sirna combinations
12/06/2012US20120308640 Amphiphilic janus-dendrimers
12/06/2012US20120308635 Melt extruded thin strips containing coated pharmaceutical
12/06/2012US20120308633 Nanostructured material formulated with bone cement for effective antibiotic delivery
12/06/2012US20120308629 Injectable bulking compositions
12/06/2012US20120308621 Base formulation for cosmetic products
12/06/2012US20120308617 Phospholipid-based inhalation system
12/06/2012US20120308616 Submicro emulsion of paclitaxel using steroid complex as intermediate carrier
12/06/2012US20120308614 Composition for the controlled release of buprenorphine
12/06/2012US20120308613 Formulations for use in inhaler devices
12/06/2012US20120308612 Compositions and methods for preparation of poorly water soluble drugs with increased stability
12/06/2012US20120308609 6-amino-2--9-[5-(1-piperidinyl)-7,9-dihydro-8h-purin-8-one maleate
1 ... 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 ... 7860